The efficacy of PSL-loaded PLGA-PEG-PLGA NPs against ACD was investigated by administering PSL-loaded PLGA-PEG-PLGA NPs to CHS model mice and observing the behavior of TNF-α and IL-4. The gene discussed is IL4; the disease is granular corneal dystrophy type II.